How CHI St. Alexius Protects Patients Through Antibiotic Stewardship and Hospital-Wide Infection Prevention Programs

Every year, millions of patients worldwide acquire infections during what should have been a safe hospital stay. Healthcare-associated infections (HAIs) are a leading cause of preventable harm and, in serious cases, death. Against the backdrop of rising antibiotic resistance—a global public health emergency that makes once-treatable infections harder to manage—hospitals face a dual challenge: prevent infections from occurring while using antibiotics wisely enough to preserve their long-term effectiveness. St Alexius Medical Center, part of the CommonSpirit Health network, has built a structured, evidence-based response to this challenge. Through CHI St. Alexius’s antibiotic stewardship program and hospital-wide infection prevention initiatives, the institution has established a layered approach to patient safety that addresses infection risk from the moment of admission through discharge.

The Real Cost of Healthcare-Associated Infections

The scale of the HAI problem in the United States is significant. According to the Centers for Disease Control and Prevention (CDC), approximately one in 31 hospitalized patients has at least one HAI on any given day. These infections—including central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), surgical site infections (SSIs), ventilator-associated events (VAEs), and Clostridioides difficile (C. diff) infections—extend hospital stays, increase healthcare costs, and cause measurable patient harm.

Compounding this problem is the accelerating threat of antimicrobial resistance. When antibiotics are prescribed unnecessarily or used at the wrong dose or for the wrong duration, bacteria can evolve to survive treatment, leaving physicians with a narrowing set of effective options. The World Health Organization has identified antimicrobial resistance as one of the top ten global public health threats of our time. This reality places institutions like St Alexius Medical Center at the front line of a challenge that demands both clinical urgency and systematic precision.

What Is Antibiotic Stewardship and Why Does It Matter?

Antibiotic stewardship is a coordinated set of strategies designed to optimize how antibiotics are prescribed and used within a healthcare setting. The objective is not to restrict access to necessary treatment—it is to ensure that every patient receives the right antibiotic, at the right dose, for the right duration, based on the best available clinical evidence. Effective stewardship reduces resistance pressure, lowers rates of antibiotic-related side effects, and improves patient outcomes across the board.

The following core principles guide well-designed antibiotic stewardship programs:

  • Prospective audit and feedback: Clinical pharmacists or infectious disease specialists review active antibiotic prescriptions and recommend adjustments based on current microbiological data and clinical progress.
  • Formulary restriction: Certain broad-spectrum or last-resort antibiotics require pre-authorization, limiting unnecessary use and protecting these agents for cases where they are truly needed.
  • De-escalation: Once culture and sensitivity results are available, therapy is narrowed to the most targeted effective agent rather than continuing broad-spectrum coverage.
  • Evidence-based duration guidelines: Treatment lengths are defined by clinical evidence rather than convention, preventing unnecessarily long antibiotic courses.
  • Local susceptibility reporting: Facility-specific resistance data is analyzed and shared with prescribers regularly to guide safer empiric treatment decisions.

These principles create a practical clinical framework that makes stewardship an active part of daily patient management—not an administrative layer applied after the fact.

CHI St. Alexius’s Antibiotic Stewardship Program in Practice

The antibiotic stewardship program at St Alexius Medical Center is grounded in the guidelines developed by the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), and the CDC. CHI St. Alexius has assembled a multidisciplinary team responsible for implementing these principles consistently across every unit of the hospital.

Who Drives the Program?

Strong stewardship requires collaboration across disciplines. Rather than placing responsibility on a single department, St Alexius Medical Center distributes stewardship accountability across a team of clinical professionals with distinct but complementary expertise. The roles central to program success include the following:

  • Infectious disease physicians who provide expert clinical guidance on complex cases and set prescribing standards for the facility.
  • Clinical pharmacists who review antibiotic prescriptions in real time, flag potential overuse, and recommend de-escalation when culture data permits.
  • Microbiologists who analyze culture results and local resistance patterns to inform both empiric and definitive treatment decisions.
  • Infection preventionists who connect stewardship data with HAI surveillance, identifying how antibiotic use patterns relate to infection trends.
  • Bedside nurses and attending physicians trained to apply stewardship principles during daily rounds and patient care interactions.

This team structure ensures that stewardship is embedded in clinical workflows rather than handled exclusively by specialists—making it a shared responsibility that reaches every patient encounter.

Key Stewardship Strategies at a Glance

The table below summarizes the primary strategies CHI St. Alexius employs within its antibiotic stewardship program, along with the clinical purpose and expected outcome of each approach:

Strategy Clinical Purpose Expected Outcome
Prospective audit and feedback Review active prescriptions for clinical appropriateness Reduces unnecessary antibiotic use
Formulary restriction Limit access to broad-spectrum or high-risk agents Decreases resistance pressure
De-escalation protocols Narrow therapy once culture data is available Lowers exposure to unnecessary antibiotics
Evidence-based duration guidelines Define optimal treatment lengths by condition Prevents overtreatment and side effects
Local susceptibility reporting Share real-time resistance data with prescribers Guides safer empiric therapy decisions

Together, these strategies form a comprehensive framework that makes antibiotic use at St Alexius Medical Center purposeful, data-driven, and aligned with current clinical evidence—ensuring that the antibiotics patients receive today remain effective for patients in the future.

Hospital-Wide Infection Prevention Programs

Antibiotic stewardship and infection prevention are two sides of the same coin. While stewardship focuses on how antibiotics are used, infection prevention focuses on stopping infections from occurring at all. St Alexius Medical Center maintains a robust infection prevention infrastructure staffed by credentialed infection preventionists who monitor the entire facility for HAI trends, investigate clusters when they appear, and drive improvement across clinical departments.

Evidence-Based Prevention Protocols

CHI St. Alexius implements structured infection prevention bundles—sets of evidence-based practices that, when applied consistently, significantly reduce the risk of specific HAI types. The following protocols are active across the facility:

  • CLABSI Prevention: Strict sterile technique during central line insertion, daily review of whether each line remains clinically necessary, and standardized dressing change procedures to minimize contamination risk.
  • CAUTI Prevention: Aseptic catheter insertion training, daily assessment of catheter necessity, and early removal protocols activated as soon as the clinical indication for catheterization no longer applies.
  • Surgical Site Infection Prevention: Pre-operative skin preparation standards, timed prophylactic antibiotic administration to ensure peak tissue levels at incision, and structured post-operative wound monitoring protocols.
  • Ventilator-Associated Event Prevention: Head-of-bed elevation requirements, oral hygiene protocols to reduce aspiration risk, and daily sedation interruption assessments to minimize ventilation duration.
  • C. diff Prevention: Contact isolation precautions for confirmed cases, enhanced environmental cleaning using sporicidal disinfectants capable of eliminating C. diff spores, and targeted antibiotic stewardship to reduce unnecessary antibiotic use that disrupts protective gut flora.

These bundles are not static protocols—they are regularly reviewed and updated in response to new clinical evidence, regulatory guidance, and internal performance data that reflects real-world outcomes at the facility.

Hand Hygiene and Environmental Decontamination

Among all infection control measures, hand hygiene remains the most fundamental and consistently effective intervention available. St Alexius Medical Center enforces compliance with the World Health Organization’s Five Moments for Hand Hygiene framework, which identifies the specific points during patient care when hand hygiene is non-negotiable. Compliance monitoring programs help infection preventionists identify practice gaps and target education where it is most needed.

Environmental decontamination is equally critical, particularly in high-risk areas including intensive care units, surgical suites, and isolation rooms. CHI St. Alexius uses EPA-registered sporicidal disinfectants and structured cleaning checklists to ensure thorough, consistent room turnover. Special attention is directed at frequently touched surfaces known to harbor persistent pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and C. diff spores.

Protecting High-Risk Patients: Targeted Precautions

Not every patient carries the same infection risk. ICU patients, post-surgical patients, immunocompromised individuals, and elderly patients are disproportionately vulnerable to HAIs and antibiotic-resistant organisms. St Alexius Medical Center addresses this through population-specific protocols that add meaningful layers of protection on top of standard care measures for the patients who need them most.

When a patient is identified as colonized or infected with a multidrug-resistant organism (MDRO)—such as MRSA, C. diff, or carbapenem-resistant Enterobacteriaceae (CRE)—transmission-based precautions are immediately activated. The following measures are implemented to contain transmission risk throughout the facility:

  • Placement in a single-occupancy room to prevent patient-to-patient spread through shared spaces.
  • Use of personal protective equipment—gowns and gloves—by all personnel entering the patient’s room, without exception.
  • Dedicated medical equipment assigned exclusively to that room, reducing the risk of cross-contamination between patients.
  • Clear visual alerts at the room entrance notifying all staff and visitors of active precautions before entry.
  • Structured education for patients and families explaining what the precautions mean, why they are in place, and how loved ones can participate safely in patient care.

These precautions reflect a systems-level approach that engages patients, families, and the full care team as equal partners in preventing the spread of dangerous pathogens within the hospital environment.

Surveillance, Data, and Continuous Improvement

CHI St. Alexius’s infection prevention programs are not driven by intuition—they are guided by real-time surveillance data. Infection preventionists at St Alexius Medical Center report HAI rates to the National Healthcare Safety Network (NHSN), the CDC’s national surveillance platform, using standardized definitions and methodology. This enables the facility to compare performance against national benchmarks and target areas most in need of improvement.

Ongoing data review enables the infection prevention team to take the following actions:

  • Detect early signals of outbreaks or infection clusters before they escalate into larger problems.
  • Pinpoint specific units or procedures with elevated HAI rates that warrant deeper root-cause investigation.
  • Measure the real-world impact of new protocols and make evidence-based adjustments when results fall short of targets.
  • Report performance transparently to hospital leadership, accrediting bodies, and regulatory agencies.

The table below summarizes the HAI types monitored at St Alexius Medical Center, the corresponding prevention strategies in place, and the standardized metrics used to assess program effectiveness:

HAI Type Primary Prevention Strategy Metric Tracked
CLABSI Insertion bundle and daily line necessity review Infections per 1,000 catheter-days
CAUTI Aseptic insertion and early catheter removal Infections per 1,000 catheter-days
Surgical Site Infection Pre-operative optimization and prophylactic antibiotic timing Infections per procedure type
C. diff Stewardship, contact isolation, and sporicidal cleaning Infections per 10,000 patient-days
Ventilator-Associated Event Evidence-based ventilator care bundle Events per 1,000 ventilator-days

Tracking these metrics consistently enables St Alexius Medical Center to hold its programs accountable and demonstrate meaningful progress—both to the clinical teams driving improvement and to the patients and communities who depend on them.

Education: Building a Culture of Prevention

Programs and protocols are only as effective as the people who implement them. CHI St. Alexius recognizes that sustainable infection prevention depends on an institutional culture in which every staff member, patient, and visitor is an active participant in safety—not a passive bystander.

Clinical Staff Training and Competency

Clinical staff at St Alexius Medical Center complete regular, structured training on infection prevention standards, antibiotic stewardship principles, and the correct application of transmission-based precautions. Competency verification ensures that knowledge translates into consistent practice at the bedside. Training curricula are updated in response to new pathogens, evolving evidence, and changes in regulatory requirements—keeping the workforce current rather than reliant on outdated practices.

Patient and Family Engagement

CHI St. Alexius provides patients and their families with clear, accessible information about the infection prevention measures in place throughout their hospital stay. Patients are educated on why hand hygiene matters, how catheter care works, what isolation precautions involve, and which steps they should take after discharge to reduce the risk of complications at home. When patients understand what is happening and why, they are more likely to follow through on protective behaviors and recognize early warning signs that warrant prompt attention.

Regulatory Compliance and Accreditation

St Alexius Medical Center
maintains full compliance with infection prevention and antibiotic stewardship standards established by The Joint Commission, the Centers for Medicare and Medicaid Services (CMS), and the CDC. While accreditation requirements define a regulatory baseline, CHI St. Alexius treats those standards as a starting point rather than a ceiling, consistently pursuing a higher threshold of clinical excellence through internal quality improvement initiatives.

Regular internal audits, department-level reviews, and leadership accountability structures keep infection prevention priorities visible and well-resourced at every level. These governance mechanisms allow St Alexius Medical Center to respond decisively when performance indicators signal a need for course correction—ensuring improvement is ongoing rather than episodic.

Conclusion

Infection prevention and antibiotic stewardship are not separate programs—they are deeply interconnected disciplines that together define a hospital’s commitment to patient safety. The approach taken by St Alexius Medical Center illustrates what these programs look like when built with genuine intent: multidisciplinary teams, evidence-based care bundles, real-time surveillance data, and a sustained investment in education at every level. CHI St. Alexius’s work in this space reflects a clear understanding that protecting patients from infection is not a background operational task—it is one of the most direct expressions of clinical quality a hospital can deliver. As antibiotic resistance continues to narrow treatment options globally, the stewardship and prevention infrastructure at CHI St. Alexius positions the facility to deliver safer, more effective care—not only for today’s patients but for those who will follow.

Scroll to Top